The first clinical trial of this approach in 7 patients with peripheral lung cancer has shown promising results. An investigator-initiated clinical trial of photodynamic therapy for peripheral ...

Among these, Vascular Targeted Photodynamic Therapy (VTP) has gained attention for its innovative approach and promising ... including pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung ...

Preliminary results from a phase 3 trial demonstrate that photodynamic therapy with Ameluz (aminolevulinic acid HCl) led to complete clearance of a target lesion in patients with superficial basal ...

ImPact Biotech is an advanced clinical-stage oncology company focused on the development and commercialization of Padeliporfin Vascular Targeted Photodynamic ... small cell lung cancer (NSCLC).

Key updated preliminary results from the Phase 3 ENLIGHTED study of Padeliporfin VTP: Padeliporfin VTP was well-tolerated with a safety profile consistent with the previous data obtained from the ...